Skip to content

Latest News

USFDA issues Form 483 with five inspectional observations to Marksans Pharma#39;s Goa unit

USFDA issues Form 483 with five inspectional observations to Marksans Pharma#39;s Goa unit

The US Food and Drug Administration (USFDA) had conducted a routine current Good Manufacturing Practices (cGMP) inspection at the manufacturing facility from April 9-17, 2024, the company said in a regulatory filing. Read More ​ The US Food and Drug Administration… Read More »USFDA issues Form 483 with five inspectional observations to Marksans Pharma#39;s Goa unit

en_USEnglish